Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Compiled Due Diligence 09/29/19 & more ********

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
XenaLives Member Profile
Member Level 
Followed By 359
Posts 47,098
Boards Moderated 28
Alias Born 09/20/01
160x600 placeholder
Anavex Life Sciences Announces Participation at Upcoming Worldwide National Institutes of Health (NIH) Panel at Rare Disease ... GlobeNewswire Inc. - 2/22/2021 7:00:00 AM
Nextech AR (OTCQB: NEXCF) $13 million Deal, Guidance to $50-60 Million, $8.60 Valuation InvestorsHub NewsWire - 2/22/2021 6:18:20 AM
Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit GlobeNewswire Inc. - 2/19/2021 7:00:00 AM
Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021 GlobeNewswire Inc. - 2/18/2021 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 4:07:35 PM
Nextech AR (OTCQB: NEXCF) 2021 Guidance $50-60 Million Closes 2020 with $20 million. InvestorsHub NewsWire - 2/12/2021 6:26:34 AM
Anavex Life Sciences EPS in-line Seeking Alpha - 2/11/2021 7:22:45 AM
Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook GlobeNewswire Inc. - 2/11/2021 7:00:00 AM
Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2... GlobeNewswire Inc. - 2/8/2021 7:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/2/2021 3:17:03 PM
Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73 (blarcamesine) in People wit... GlobeNewswire Inc. - 1/11/2021 7:00:00 AM
Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect Conference GlobeNewswire Inc. - 1/6/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:28:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:26:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:25:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:23:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:20:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/28/2020 5:29:22 PM
Annual Report (10-k) Edgar (US Regulatory) - 12/28/2020 5:28:26 PM
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates GlobeNewswire Inc. - 12/28/2020 7:00:00 AM
Biotech Report; Upcoming FDA Reviews and Promising Pipelines InvestorsHub NewsWire - 12/22/2020 8:20:00 AM
Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020 GlobeNewswire Inc. - 12/22/2020 7:00:00 AM
Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX®2-73 (Blarcamesine) Phase 2 Data hosted by Ladenburg Thal... GlobeNewswire Inc. - 12/21/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2020 7:09:21 AM
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. P... GlobeNewswire Inc. - 12/15/2020 7:00:00 AM
XenaLives Member Level  Thursday, 10/22/20 10:46:56 PM
Re: None
Post # of 300669 
Compiled Due Diligence 09/29/19 & more ********

See this link:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151418975


******* Possible meetings for data presentation *******

October 28-29, 2020 9.00-17.30 EDT | Virtual Event
The inaugural Protein Misfolding Drug Discovery Digital Summit
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159044103

November 04, 2020 - November 07, 2020
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158942181

Friday, November 6 Confirmed late breaking presentaton:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159068231

November 16-17, 2020
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158943623

November 17, 2020[/b
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158968868

December 09-10, 2020
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158931494

**********************************************************************

Updated Pipeline
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159068807

Biology concepts for Alzheimer’s disease (2/20 update)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158531542

Covid and Anavex:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159068746
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159069029

Updated Trials
INSTRUCIONS TO VIEW UPDATES - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159068404
PDD - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159067462
RETT AVATAR - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159067552
RETT - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159067617
EARLY ALZHEIMER'S - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159067667

New Parkinson’s news article re our positive PD Dementia trial results (from polarbear77)
https://parkinsonsnewstoday.com/2020/10/19/anavex-2-73-safe-aids-cognitive-skills-parkinsons-dementia-patients-phase-2-trial/

Actigraph will give objective sleep data:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158938705

The slide that mentions Actigraphy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158955971

More comments on Actigraphy
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157152758

Sleep - a few of many papers released within the last year:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158942413

PubChem reference for 2-73
https://pubchem.ncbi.nlm.nih.gov/compound/Anavex-2-73#section=Chemical-Disease-Co-Occurrences-in-Literature
see also this post on pubchem info:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158822687

A new study finds new ways of detecting early, asymptomatic Alzheimer's disease (from falconer66):
https://www.eurekalert.org/pub_releases/2020-10/wsu-rdm101920.php

Effect of Peroxynitrite:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158822263

Autism and Mitochondrial Dysfunction:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158964035
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158964348


TGA requirements have been discussed for years here.
OLE's may be as valuable as a trial for the purpose of Provisional approval.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158539684

ER–mitochondria signaling in Parkinson’s disease (from mapman's link to article post below)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142355746&txt2find=autophagy
PDF of the article cited:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832754/pdf/41419_2017_Article_79.pdf
From "Compiled: MOA and MEDICAL SCIENCE DISCUSSION 09/29/19" at the following link:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151418911

ALS and gut bacteria linked in “remarkable” new Harvard study (from georjejjl)
https://newatlas.com/science/als-gut-bacteria-microbiome-harvard-study/
https://www.anavex.com/wp-content/uploads/2019/12/CTAD2019_ANAVEX2-73_P84_Microbiota_.pdf

From MS Today and tradeherpete “Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis”:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155546193

Aarsland has been busy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158700775

Biostockclub holds forth :)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158688526

Basic info on PDD from nidan:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158724733

Air pollution particles in young brains linked to Alzheimer's damage
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158774113

Faster drug approval coming world wide:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158796012

Ransomware attack possible reason for delay in PDD trial data:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158710802
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158748463
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158797284

The key lies in being able to accelerate the rate of failure.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158828376

August 15, 2020 Media report on Rett Syndrome trial in Australia.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158829938

COGNITION IN PARKINSON'S
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158855354

Anavex 2-73 made with the SCF, supercritical fluid, for increased bioavaliability.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158825826

From JF comm. 10/08/20, w/ interesting PD comments and future---something about news in October:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158790564

Some of the scientific resources that MJFF utilizes, coordinates and makes available...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158897015
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158897404







Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences